{"id":"NCT00988884","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"A Study of V503 Given Concomitantly With Menactra™ and Adacel™ in 11 to 15 Year Olds (V503-005)","officialTitle":"A Phase III Open-Label Clinical Trial to Study the Immunogenicity and Tolerability of V503 (A Multivalent Human Papillomavirus [HPV] L1 Virus-Like Particle [VLP] Vaccine) Given Concomitantly With Menactra™ and Adacel™ in Preadolescents and Adolescents (11 to 15 Year Olds)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-10-21","primaryCompletion":"2011-02-22","completion":"2011-02-22","firstPosted":"2009-10-02","resultsPosted":"2015-01-13","lastUpdate":"2018-12-14"},"enrollment":1241,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"PREVENTION"},"conditions":["Human Papillomavirus Infection"],"interventions":[{"type":"BIOLOGICAL","name":"V503","otherNames":[]},{"type":"BIOLOGICAL","name":"Comparator: Menactra™ (Concomitant)","otherNames":[]},{"type":"BIOLOGICAL","name":"Comparator: Adacel™ (Concomitant)","otherNames":[]},{"type":"BIOLOGICAL","name":"Comparator: Menactra™ (Non-Concomitant)","otherNames":[]},{"type":"BIOLOGICAL","name":"Comparator: Adacel™ (Non-concomitant)","otherNames":[]}],"arms":[{"label":"Concomitant Vaccination","type":"EXPERIMENTAL"},{"label":"Non-concomitant Vaccination","type":"EXPERIMENTAL"}],"summary":"This study will evaluate the tolerability and immunogenicity of administration of the first dose of V503 at the same time as Menactra™ and Adacel™ versus administration of V503 one month prior to administration of Menactra™ and Adacel™.","primaryOutcome":{"measure":"Geometric Mean Titers (GMTs) of the Antibody Response to Each of the Human Papillomavirus (HPV) Types Contained in V503","timeFrame":"4 weeks following Month 6 vaccination","effectByArm":[{"arm":"Concomitant Vaccination","deltaMin":2198.7,"sd":null},{"arm":"Non-concomitant Vaccination","deltaMin":2260.7,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"},{"comp":"OG000 vs OG001","p":"<0.001"},{"comp":"OG000 vs OG001","p":"<0.001"},{"comp":"OG000 vs OG001","p":"<0.001"},{"comp":"OG000 vs OG001","p":"<0.001"},{"comp":"OG000","p":"<0.001"},{"comp":"OG000 vs OG001","p":"<0.001"},{"comp":"OG000 vs OG001","p":"<0.001"},{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"11 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":4,"exclusionCount":13},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["26290207","26240207","27422279"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":5,"n":613},"commonTop":["Injection-site pain","Injection-site swelling","Injection-site erythema","Headache","Pyrexia"]}}